Please login to the form below
Astellas picks PhRMA’s Uhlendorf for US public affairs lead
He will leave his role as VP, communications and public affairs at US trade body
Astellas has named Karl Uhlendorf to lead public affairs efforts across its Americas business.
Uhlendorf, who joins Astellas on July 28, currently serves as VP, communications and public affairs at the US trade body the Pharmaceutical Research & Manufacturers of America (PhRMA).
In his new role as communications and advocacy director he will be responsible for strengthening Astellas' media and advocacy presence in Washington DC as well as providing strategic communications counsel to the Astellas' corporate communications and government affairs team.
Uhlendorf has significant experience in the area, having spent seven years at PhRMA in communications and public affairs roles.
Margaret Long, Astellas' VP, business communications and advocacy, said: "We are eager to leverage Karl's expertise in a number of key focus areas, namely media, public affairs and advocacy."
The company added that Uhlendorf's appointment was “the latest phase in the building of the new US corporate communications team”. Other recent appointments include former Lilly comms chief Jeff Winton as senior VP, chief communications officer.
Subscribe to our email news alerts
- Sanofi and Teva to collaborate on inflammatory bowel disease drug in deal worth $1.5bn
- Eli Lilly to acquire cancer specialist Point Biopharma in deal worth $1.4bn
- Regeneron and Intellia to develop additional gene editing therapies under expanded collaboration
- Novavax’s updated COVID-19 vaccine approved by FDA for emergency use
- Alzheimer’s Research UK awards Cardiff University researchers £387,000
- Actinic keratosis – a common skin condition that can lead to skin cancer
No results were found
PMHub
Oncosec
OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...
Latest intelligence
- Actinic keratosis – a common skin condition that can lead to skin cancer
- PMGroup talks to Volker Koscielny, Chief Medical Officer at Almirall, about the importance of remaining vigilant about skin checks, the prevalence of actinic keratosis in the UK and the steps...
- Man vs microbe: the fight against antimicrobial resistance
- How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics...
- Is trust the key factor in digital HCP engagement? New whitepaper from Graphite Digital
- Based on research with HCPs in the UK, USA and France, Graphite Digital’s latest whitepaper sheds light on HCP perceptions of pharma-owned digital channels, and what organisations should be prioritising...
